Market data provided by Factset.

Mutual Fund and ETF data provided by Refinitiv Lipper.

Rival distribution brass aren’t throwing any shade on No Time to Die‘s opening, even though it’s the third-best, currently behind Skyfall ($88.3M) and Spectre ($70.4M); in fact, they’re thrilled.

Consider the fact that No Time to Die‘s opening is right around where Mission: Impossible – Fallout ($61.2M) and Mission: Impossible – Rogue Nation ($55.5M) opened stateside.

DANIEL CRAIG AND RAMI MALEK SURPRISE AUDIENCE AT BURBANK IMAX BEFORE ‘NO TIME TO DIE’ SHOWING.

‘No Time To Die' starring Daniel Craig grossed $23.3 million on its opening day in the United States.

—No Time to Die‘s opening day is the fourth-best among the Craig titles, behind Skyfall‘s $32.7M, Spectre‘s $27.4M, and Quantum of Solace‘s $27M.

‘NO TIME TO DIE’ THRIVING WITH PROJECTED $113M OFFSHORE BOW- INTERNATIONAL BOX OFFICE.

–The latest Bond gets an A- CinemaScore, which is the same as Spectre, Casino Royale, and even Pierce Brosnan’s finale as Bond, Die Another Day. It’s higher than Quantum of Solace, the lowest-graded of the Craig movies at B-, yet under Skyfall, which landed an A. No Time to Die clocked an 81% positive score on PostTrak, and a 62% definite recommend.

Second weekend holds on previous Craig Bond pics were -52% on Spectre and -53% on Skyfall. .

On opening day, 22% of patrons saw No Time to Die in Large Format vs. Venom 2‘s opening day which saw 26% from those auditoriums.

Sony’s Venom: Let There Be Carnage took in $8.85M on Friday, -76% from a week ago, on its way to a $31.1M second weekend, -65% for a running total by EOD Sunday of $140.8M, which, compared to the first Venom‘s ten-day running total, is just -1% behind; which is really great.

The first Venom saw a second weekend decline of -56% of $35M.

‘NO TIME TO DIE’ REVIEW: DANIEL CRAIG DELIVERS A THRILLING AND EMOTIONAL EXIT TO HIS JAMES BOND.